dr. powles on potential for durvalumab in renal cancer
Published 5 years ago • 203 plays • Length 2:05Download video MP4
Download video MP3
Similar videos
-
1:10
dr. powles discusses the future of durvalumab in bladder cancer
-
1:18
dr. powles on durvalumab in urothelial cancer
-
1:33
dr. powles on the impact of immunotherapy in kidney cancer
-
2:16
savolitinib plus durvalumab show promise in papillary renal cancer: calypso results
-
1:34
dr. powles on bevacizumab plus atezolizumab in kidney cancer
-
1:52
dr. powles on monitoring immunotherapy effects in patients with rcc
-
1:34
dr. powles on rationale for keynote-426 in mrcc
-
2:16
dr. powles on biomarkers for immunotherapy in bladder cancer
-
0:35
potential of immunotherapy for kidney cancer
-
3:19
fda approval of durvalumab for advanced bladder cancer
-
7:20
emerging immunotherapy combinations in kidney cancer
-
2:16
dr. rini on axitinib for treatment of metastatic renal cell carcinoma
-
1:50
dr. powles on the current state of research in bladder cancer
-
2:03
durvalumab fda approval for bladder cancer
-
1:40
dr. powles on fda approval of pembrolizumab plus axitinib in advanced rcc
-
1:06
exciting potential of pembrolizumab combined with axitinib for kidney cancer
-
1:19
dr. clark on the potential of immunotherapy in renal cell carcinoma
-
0:47
dr. feldman on durvalumab for patients with lung cancer
-
4:38
danube trial: durvalumab alone or with tremelimumab for metastatic bladder cancer